BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37542132)

  • 1. Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis.
    Wang M; Li J; Yang X; Yan Q; Wang H; Xu X; Lu Y; Li D; Wang Y; Sun R; Zhang S; Zhang Y; Zhang Z; Meng F; Li Y
    Cancer Gene Ther; 2023 Nov; 30(11):1485-1497. PubMed ID: 37542132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer.
    Geng Q; Liu J; Gong Z; Chen S; Chen S; Li X; Lu Y; Zhu X; Lin HK; Xu D
    Mol Cancer; 2017 Apr; 16(1):83. PubMed ID: 28446188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of RACK1 promotes glutamine addiction via activating AKT/mTOR/ASCT2 axis to facilitate tumor growth in gastric cancer.
    Chen M; Wang G; Xu Z; Sun J; Liu B; Chang L; Gu J; Ruan Y; Gao X; Song S
    Cell Oncol (Dordr); 2024 Feb; 47(1):113-128. PubMed ID: 37578594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PUM1 Promotes Tumor Progression by Activating DEPTOR-Meditated Glycolysis in Gastric Cancer.
    Yin S; Liu H; Zhou Z; Xu X; Wang P; Chen W; Deng G; Wang H; Yu H; Gu L; Huo M; Li M; Zeng L; He Y; Zhang C
    Adv Sci (Weinh); 2023 Sep; 10(27):e2301190. PubMed ID: 37469018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases.
    Dai XM; Zhang YH; Lin XH; Huang XX; Zhang Y; Xue CR; Chen WN; Ye JX; Lin XJ; Lin X
    Mol Oncol; 2021 Jan; 15(1):228-245. PubMed ID: 33128264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Gu Y; Fei Z; Zhu R
    Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine fungus-derived alkaloid inhibits the growth and metastasis of gastric cancer via targeting mTORC1 signaling pathway.
    Ma S; Hu Y; Chen J; Wang X; Zhang C; Liu Q; Cai G; Wang H; Zheng J; Wang Q; Zhong L; Yang B; Zhou S; Liu Y; Han F; Wang J; Wang J
    Chem Biol Interact; 2023 Sep; 382():110618. PubMed ID: 37394161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MITF-MIR211 axis is a novel autophagy amplifier system during cellular stress.
    Ozturk DG; Kocak M; Akcay A; Kinoglu K; Kara E; Buyuk Y; Kazan H; Gozuacik D
    Autophagy; 2019 Mar; 15(3):375-390. PubMed ID: 30290719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
    Li Y; Gu J; Lu H
    Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming.
    Zhang ZJ; Wu QF; Ren AQ; Chen Q; Shi JZ; Li JP; Liu XY; Zhang ZJ; Tang YZ; Zhao Y; Yao NN; Zhang XY; Liu CP; Dong G; Zhao JX; Xu MJ; Yue YQ; Hu J; Sun F; Liu Y; Ao QL; Zhou FL; Wu H; Zhang TC; Zhu HC
    Acta Pharmacol Sin; 2023 Nov; 44(11):2282-2295. PubMed ID: 37280363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR.
    Ren J; Hu Z; Niu G; Xia J; Wang X; Hong R; Gu J; Wang D; Ke C
    FASEB J; 2023 Mar; 37(3):e22790. PubMed ID: 36786694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.
    Kim ST; Kim SY; Klempner SJ; Yoon J; Kim N; Ahn S; Bang H; Kim KM; Park W; Park SH; Park JO; Park YS; Lim HY; Lee SH; Park K; Kang WK; Lee J
    Ann Oncol; 2017 Mar; 28(3):547-554. PubMed ID: 28028034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rab1A knockdown represses proliferation and promotes apoptosis in gastric cancer cells by inhibition of mTOR/p70S6K pathway.
    Li Z; Li Y; Jia Y; Ding B; Yu J
    Arch Biochem Biophys; 2020 May; 685():108352. PubMed ID: 32240637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High ATF4 Expression Is Associated With Poor Prognosis, Amino Acid Metabolism, and Autophagy in Gastric Cancer.
    Wang M; Lu Y; Wang H; Wu Y; Xu X; Li Y
    Front Oncol; 2021; 11():740120. PubMed ID: 34976799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.
    Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC
    Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
    Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy.
    Ruf S; Heberle AM; Langelaar-Makkinje M; Gelino S; Wilkinson D; Gerbeth C; Schwarz JJ; Holzwarth B; Warscheid B; Meisinger C; van Vugt MA; Baumeister R; Hansen M; Thedieck K
    Autophagy; 2017 Mar; 13(3):486-505. PubMed ID: 28102733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.
    Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
    Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
    Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.